Two vs one dose vaccine schedules: assessing the evidence
Monday, December 3, 2018
Scientific Session
•
SS 03
•
4:15 PM
>
5:45 PM
•
Two vs one dose vaccine schedules: assessing the evidence
•
Auditorium II
If one dose of HPV vaccine can provide a high level of protection, then considerable cost savings and accelerate global uptake of vaccination. In this session, investigators discuss the implications of both experimental and observational studies around reduced dose vaccine schedules, as well as the use of epidemiological and economic modelling to project these results to individual countries.
4:15 PM
•
SS 03-01
•
Clinical trials: efficacy in India
>
P.
Partha
BASU
4:30 PM
•
SS 03-02
•
Modelling: potential population impact in Low and Middle-Income vs High-Income Countries
>
M.
Marc
BRISSON
4:45 PM
•
SS 03-03
•
Observational data: Reduced-dose HPV vaccination effectiveness
>
L.
Lauri
MARKOWITZ
5:00 PM
•
SS 03-04
•
Modelling: potential population impact in Uganda
>
E.
Emily
BURGER
5:15 PM
•
SS 03-05
•
Economics: cost-effectiveness of one-dose vaccination
>
M.
Mark
JIT
5:30 PM
•
SS 03-06
•
Discussion
|